http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2125386-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
filingDate 1992-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8323cfd948e2deb97355551cfaeae4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76938c33c216c324b6319e2c1a0063cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab87c51956d8567daa33c0172a4d4396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2d1c4136631fafca72b2b3e4a3e604
publicationDate 1993-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2125386-A1
titleOfInvention Novel use of 2-nitroxyethyl (+)apovincaminate
abstract ABSTRACT Object: There are provided an agent for relieving disturbance of consciousness and a narcotic antagonist which are novel. Construction: An agent for relieving disturbance of consciousness which contains 2-nitroxyethyl (+)apo-vincaminate as an active ingredient, and a narcotic antagonist containing 2-nitroxyethyl (+)apovincaminate as an active ingredient.
priorityDate 1991-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID414344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638678
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397780
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373666
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589196
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62968
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4474
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448766180
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54XS1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450780679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415857324
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17276
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613414
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878539
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38121
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID266721
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452902028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192

Total number of triples: 55.